Skip to main content
Premium Trial:

Request an Annual Quote

Patent Watch: Mar 20, 2009


Cyntellect has been awarded US Patent 7,505,618, "Method and apparatus for selectively targeting specific cells within a cell population."

The inventors listed on the patent are Bernhard Palsson, Manfred Koller, and Timothy Eisfeld.

As stated in its abstract, the patent provides a method and apparatus for selectively identifying, and targeting with an energy beam, specific cells within a cell population, for the purpose of inducing a response in the targeted cells. The present invention can identify and affect every detectable cell in a population, without substantially affecting non-targeted cells within the mixture.

The University of Michigan has been awarded US Patent 7,504,234, "Assays for S-adenosylmethionine (AdoMet)-dependent methyltransferase activity."

The inventors listed on the patent are Raymond Trievel, Evys Collazo-Santiago, and Jean-Francois Couture.

The patent relates to coupled enzyme assays, according to its abstract. In particular, the patent provides a coupled fluorescent assay for detection of S-adenosylmethionine-dependent methyltransferase activity and S-adenosylhomocysteine hydrolase enzyme activity.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.